Promed
promed.com.au
Actively hiring
Hospitals & Clinics
Cybersecurity
Health Care
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
Pro Medicus is an Australian health imaging software company whose Visage platform streams large radiology studies rapidly. Its technology is used by major United States academic hospitals and imaging networks. The company is listed in Australia and is one of its best performing technology stocks.
News
Dr Sam Hupert Interview
CEO Interview FY26 Results - Acrobat pdf 307k 18 August 2026 Interview with Dr Sam Hupert, CEO Pro Medicus Limited: Full-Year results AI-Visage-The Gateway Cardiology and new developments - Digital Pathology and Reporting Implementations and timing of rev
Read more
Report
Pro Medicus Limited Full-Year Results
18 August 2026; PME Full Year Results FY26 - Acrobat pdf 431k Highlights Reported Performance Revenue $261.7m - up 22.9% Underlying EBIT - $196.1m - up 24.4% NPAT $265.3m - up 130.3% Underlying NPAT $144.7m - up 24.1% Company remains debt-free with cash a
Read more
Report
Dr Sam Hupert Interview
CEO Interview HY26 results - Final - Acrobat pdf 115k 12 February 2026 Interview with Pro Medicus CEO, Dr Sam Hupert, where he discussed: Half-Year results Sales and implementation update Investment in 4DX Impact of AI - disruptor or not Update on Cardiol
Read more
Report
Pro Medicus Limited Interim Results
12 February 2026; Company Announcement - Pro Medicus Limited Interim Results - Acrobat pdf 150k Highlights Revenue from ordinary activities $124.8m - up 28.4% Underlying profit before tax $90.7m - up 29.7% Reported net profit after tax $171.2m - up 230.9%
Read more
Report
Dr Sam Hupert Interview
CEO Interview 2024-2025 Full-Year Results - Acrobat pdf 155k 14 August 2025 Interview with Pro Medicus CEO, Dr Sam Hupert, where he discussed: Full-Year results Sales and implementation update Cloud and other factors driving the industry Update on Cardiol
Read more
Report
Pro access
Upgrade to see all 20 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.